Additionally, ResMed is set to enhance its capabilities after acquiring VirtuOx, a leading diagnostic testing entity for sleep and respiratory conditions, which positions the company to deliver improved care. As ResMed looks ahead, it is focused on innovation and partnerships to expand access to healthcare solutions for patients globally. Investors can tune into ResMed's conference call to delve deeper into these results, with the live webcast available on the company's investor relations page.